NO179313C - Fremgangsmåte ved fremstilling av divalent vaksine virksom mot Pseudomonas aeruginosa - Google Patents

Fremgangsmåte ved fremstilling av divalent vaksine virksom mot Pseudomonas aeruginosa

Info

Publication number
NO179313C
NO179313C NO893442A NO893442A NO179313C NO 179313 C NO179313 C NO 179313C NO 893442 A NO893442 A NO 893442A NO 893442 A NO893442 A NO 893442A NO 179313 C NO179313 C NO 179313C
Authority
NO
Norway
Prior art keywords
pseudomonas aeruginosa
against pseudomonas
flagella
effective against
serotype
Prior art date
Application number
NO893442A
Other languages
English (en)
Norwegian (no)
Other versions
NO893442L (no
NO179313B (no
NO893442D0 (no
Inventor
Heinz Rotering
Johann Eibl
Friedrich Dorner
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag filed Critical Immuno Ag
Publication of NO893442D0 publication Critical patent/NO893442D0/no
Publication of NO893442L publication Critical patent/NO893442L/no
Publication of NO179313B publication Critical patent/NO179313B/no
Publication of NO179313C publication Critical patent/NO179313C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1214Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Pseudomonadaceae (F)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO893442A 1988-08-29 1989-08-28 Fremgangsmåte ved fremstilling av divalent vaksine virksom mot Pseudomonas aeruginosa NO179313C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0211388A AT390192B (de) 1988-08-29 1988-08-29 Gegen pseudomonas aeruginosa-infektionen wirksame praeparationen sowie immunglobuling-h|ltige, gegen bakterium pseudomonas aeruginosa wirksame praeparationen

Publications (4)

Publication Number Publication Date
NO893442D0 NO893442D0 (no) 1989-08-28
NO893442L NO893442L (no) 1990-03-01
NO179313B NO179313B (no) 1996-06-10
NO179313C true NO179313C (no) 1996-09-18

Family

ID=3528050

Family Applications (1)

Application Number Title Priority Date Filing Date
NO893442A NO179313C (no) 1988-08-29 1989-08-28 Fremgangsmåte ved fremstilling av divalent vaksine virksom mot Pseudomonas aeruginosa

Country Status (10)

Country Link
US (1) US5324511A (fr)
EP (1) EP0357585B1 (fr)
JP (1) JPH0813752B2 (fr)
AT (2) AT390192B (fr)
CA (1) CA1302882C (fr)
DE (1) DE58907391D1 (fr)
DK (1) DK417689A (fr)
ES (1) ES2055164T3 (fr)
FI (1) FI95003C (fr)
NO (1) NO179313C (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994008617A1 (fr) * 1992-10-16 1994-04-28 Brigham And Women's Hospital, Inc. Antigenes d'acide alginique o-derives
IL120202A (en) * 1996-03-07 2001-03-19 Akzo Nobel Nv Container with freeze-dried vaccine components

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60248625A (ja) * 1984-05-25 1985-12-09 Mitsui Toatsu Chem Inc 抗緑膿菌モノクロ−ナル抗体、その製法ならびに用途
AT384032B (de) * 1985-01-14 1987-09-25 Immuno Ag Verfahren zur herstellung von polydispersen nativen pseudomonas-flagella(h)-antigenen (fag)
US4693891A (en) * 1985-09-09 1987-09-15 Miles Laboratories, Inc. Vaccine for Pseudomonas aeruginosa
AT391080B (de) * 1986-06-24 1990-08-10 Immuno Ag Verfahren zur herstellung von gegen pseudomonas aeruginosa infektionen wirksamen praeparationen

Also Published As

Publication number Publication date
EP0357585B1 (fr) 1994-04-06
NO893442L (no) 1990-03-01
ATA211388A (de) 1989-09-15
CA1302882C (fr) 1992-06-09
US5324511A (en) 1994-06-28
FI95003B (fi) 1995-08-31
DK417689A (da) 1990-03-01
AT390192B (de) 1990-03-26
DK417689D0 (da) 1989-08-24
JPH02108634A (ja) 1990-04-20
ATE103817T1 (de) 1994-04-15
ES2055164T3 (es) 1994-08-16
EP0357585A2 (fr) 1990-03-07
JPH0813752B2 (ja) 1996-02-14
EP0357585A3 (en) 1990-04-25
FI95003C (fi) 1995-12-11
NO179313B (no) 1996-06-10
NO893442D0 (no) 1989-08-28
DE58907391D1 (de) 1994-05-11
FI894048A0 (fi) 1989-08-29
FI894048A (fi) 1990-03-01

Similar Documents

Publication Publication Date Title
ES500567A0 (es) Procedimiento de preparar complejos vacunantes por reaccion de arn ribonosales y de antigenos especificos.
DE69409962D1 (de) Immuntoleranzinduzierendes agens
EP0822830A4 (fr) Anticorps humains derives d'une xenosouris immunisee
CA2033640A1 (fr) Vaccins contre le cancer et les maladies infectieuses
RU95105991A (ru) Конъюгат, вакцина, способы усиления иммуногенности, способы иммунизации
EP0306524A4 (fr) Determinants antigeniques reconnus par des anticorps obtenus au moyen d'un agent pathogene ou d'un de ces derives qui presente un groupe d'antigenes restreint.
CA2022420A1 (fr) Vaccin contre escherichia coli
CA2145397A1 (fr) Vaccins conjugues polysaccharides-proteines contre des streptocoques du groupe b de types ii et v
GR3029774T3 (en) Method of preparing a radioactive rhenium complex solution.
DK398683A (da) Fremgangsmaade til fremstilling af antistoffer
NO179313C (no) Fremgangsmåte ved fremstilling av divalent vaksine virksom mot Pseudomonas aeruginosa
EP0498804A4 (en) A method of vaccine or toxoid preparation and immunization by colonization with recombinant microorganisms
AU2032988A (en) A genus-specific listeria antigen identified by monoclonal antibodies
PT760394E (pt) Vacina de virus moderado da doenca de newcastle
GB2227936A (en) Vaccine against brucella abortus
EP0328578A4 (fr) Antigene identifie par mca 16-88.
EP0537168A4 (en) Ctaa 28a32, the antigen recognized by mca 28a32
CA2133108A1 (fr) Vaccin a base de toxoide contre pasteurella haemolytica type a-1
BR9814556A (pt) Cepas isoladas de staphylococcus aureus e vacinas fabricadas a partir das mesmas
EP0450573A3 (fr) Anticorps pour le traitement et le diagnostic d'infections de Pseudomonas aeruginosa
Zlakomanova et al. THE PREVALENS OF PERTUSSIS IN CHILDREN IN CHELYABINSK 2007-2015 YEARS AND POSTVACCINAITION IMMUNITI AGAINST PERTUSSIS
BOROWSKI INTERACTION OF PSEUDOMONAS AERUGINOSA WITH HOST HUMORAL DEFENSE MECHANISMS (CYSTIC FIBROSIS)
Lu et al. Studies on the Immunological and Serological Identification of Spotted Fever Group Rickettsiae.
DE3777196D1 (de) Anti-parathyroid-antikoerper-praeparat.